REGENXBIO Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Rockville, MD
RGNX chart
What traders are saying about $RGNX
Latest postsREGENXBIO Inc. news
- Mizuho names its top SMID biotech pick for November
Yahoo Finance ·
- REGENXBIO Inc. (RGNX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- REGENXBIO Inc. (NASDAQ:RGNX) Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St ·
- REGENXBIO Inc. (RGNX) stock price, news, quote and history
Yahoo Finance UK ·
- Regenxbio Inc (RGNX) (Q3 2026) Earnings Call Highlights: Dual Gene Therapy Catalysts Near ...
Yahoo Finance ·
- Regenxbio Stock Price Forecast. Should You Buy RGNX?
StockInvest.us ·
- Regenxbio: 2 Major Catalysts Could Change The Investment Case (NASDAQ:RGNX)
Seeking Alpha ·
- REGENXBIO Q3 Earnings Call Highlights
marketbeat.com ·
- Mizuho cuts Regenxbio stock price target on pipeline timing
Investing.com ·
- REGENXBIO (RGNX) Eyes Multiple Regulatory Milestones Amidst Chal
GuruFocus ·
- REGENXBIO (RGNX) Q3 2026 Earnings Call Transcript
fool.com ·
- Regenxbio Q3 Loss Narrows With Settlement Gain as Revenue Falls
Securities.io ·
REGENXBIO Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $170.4M | $83.3M | $90.2M | $112.7M |
| Net income | -$193.9M | -$227.1M | -$263.5M | -$280.3M |
| Diluted EPS | $-3.76 | $-4.59 | $-6.02 | $-6.50 |
| Total assets (year end) | $453.0M | $466.0M | $574.0M | $833.3M |
| Cash and equivalents (year end) | $34.5M | $57.5M | $34.5M | $97.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About REGENXBIO Inc.
- Ticker
- RGNX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Rockville, MD
- Fiscal year end
- December 31
- SEC CIK
- 1590877
- Former names
- ReGenX Biosciences, LLC
Frequently asked questions
What exchange is REGENXBIO Inc. listed on?
REGENXBIO Inc. trades on the Nasdaq under the ticker symbol RGNX.
What industry is REGENXBIO Inc. in?
REGENXBIO Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is REGENXBIO Inc. headquartered?
REGENXBIO Inc.'s business address on file with the SEC is in Rockville, MD.
When does REGENXBIO Inc.'s fiscal year end?
REGENXBIO Inc.'s fiscal year ends on December 31.
How much revenue did REGENXBIO Inc. report?
REGENXBIO Inc. reported $170.4M in revenue for calendar year 2025, according to its SEC filings.